FDA.reportPublic FDA data

linagliptin 2.5 MG / metformin hydrochloride 850 MG Oral Tablet [Jentadueto]

RxCUI
1243040
RxNorm name
linagliptin 2.5 MG / metformin hydrochloride 850 MG Oral Tablet [Jentadueto]
Display name
linagliptin 2.5 MG / metformin hydrochloride 850 MG Oral Tablet [Jentadueto]
Full name
linagliptin 2.5 MG / metformin hydrochloride 850 MG Oral Tablet [Jentadueto]
Term type
SBD
Status
DailyMed mapping
Updated
2026-06-04 23:39:28

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
JentaduetoLINAGLIPTIN AND METFORMIN HYDROCHLORIDEBoehringer Ingelheim Pharmaceuticals, Inc.f6dd9b86-0d18-95d4-2bc7-05591bfdd5972026-08-19Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 1243040

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
f6dd9b86-0d18-95d4-2bc7-05591bfdd597Jentadueto 2.5 MG / 850 MG Oral Tablet [PSN] · linagliptin 2.5 MG / metformin hydrochloride 850 MG Oral Tablet [Jentadueto] [SBD] · Jentadueto 2.5/850 Oral Tablet [SY]345These highlights do not include all the information needed to use JENTADUETO safely and effectively. See full prescribing information for JENTADUETO. JENTADUETO ® (linagliptin and metformin hydrochloride tablets), for oral use Initial U.S. Approval: 201220240627